Tasigna 150Mg Capsule
NOVARTIS INDIA LTD
ORAL
In Stock
Tasigna 150Mg Capsule belongs to the class of anticancer drugs called tyrosine kinase inhibitors used in the treatment of Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). Ph+ CML is a type of blood cancer that causes white blood cells to behave differently.
Tasigna 150Mg Capsule contains Nilotinib which works by blocking the action of an abnormal protein (Bcr-Abl tyrosine kinase) produced by an abnormal Philadelphia chromosome that signals abnormal white blood cells (cancerous cells) to multiply. Thereby, it stops the multiplication and inhibits the growth of cancerous cells and then causes the death of these cells.
Take Tasigna 150Mg Capsule as prescribed. You are recommended to take Tasigna 150Mg Capsule for as long as your doctor has advised it for you based on your medical condition. Sometimes, Tasigna 150Mg Capsule may cause common side effects such as vomiting, nausea, diarrhoea, headache, constipation, tiredness, and muscle and joint pain. Most of these side effects of Tasigna 150Mg Capsule do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, please consult your doctor.
If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Tasigna 150Mg Capsule if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Tasigna 150Mg Capsule and for two weeks after completing the course of Tasigna 150Mg Capsule. Tasigna 150Mg Capsule is not recommended for children below one year of age. Drive only if you are alert as Tasigna 150Mg Capsule may cause dizziness or visual disorders as side effects in some people. If you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Tasigna 150Mg Capsule, contact your doctor immediately, as these might be symptoms of liver problems.
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML)
Tasigna 150Mg Capsule contains Nilotinib, an anticancer drug used to treat Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML). In chronic myeloid leukemia (CML) patients, a change in genetic material (DNA) triggers a signal that tells the body to produce more abnormal white blood cells (cancerous cells). Nilotinib works by blocking this signal and thus stops the production of cancerous cells. Tasigna 150Mg Capsule is used in adults and children with newly diagnosed Ph+ CML in the chronic phase and in adults with Ph+ CML in the accelerated and chronic phase who did not tolerate or no longer benefit from other treatments, including Imatinib.
If you are allergic to Nilotinib or any other medicines, please tell your doctor. Avoid taking Tasigna 150Mg Capsule if you are pregnant or breastfeeding. You are recommended to use effective contraceptive methods while taking Tasigna 150Mg Capsule and for two weeks after completing the course of Tasigna 150Mg Capsule. Tasigna 150Mg Capsule is not recommended for children below one year of age. Tasigna 150Mg Capsule may affect the growth and development of children with chronic phase Ph+ CML. Some children and adolescents may have slower than normal growth while taking Tasigna 150Mg Capsule. Therefore, your doctor will monitor the growth of your child at regular visits. Drive only if you are alert as Tasigna 150Mg Capsule may cause dizziness or visual disorders as side effects in some people. Tasigna 150Mg Capsule may increase the risk of liver problems, especially in people with a history of liver problems. Therefore, if you have yellow skin and eyes, dark-coloured urine, or stomach pain while taking Tasigna 150Mg Capsule, contact your doctor immediately, as these might be symptoms of liver problems. Inform your doctor if you have a severe problem with lactose (milk sugar) or other sugars as Tasigna 150Mg Capsule may contain lactose. Most people who have mild or moderate lactose intolerance can take Tasigna 150Mg Capsule. Avoid taking Tasigna 150Mg Capsule if you have low levels of magnesium or potassium in the blood or long QTc syndrome. If you have had a surgical procedure involving the removal of the entire stomach (total gastrectomy), inform your doctor before taking Tasigna 150Mg Capsule.
Drug-Drug Interaction: Tasigna 150Mg Capsule may interact with anti-arrhythmic drugs (disopyramide, quinidine, amiodarone, sotalol, procainamide), antibiotics (clarithromycin, moxifloxacin), antimalarial drugs (chloroquine), antipsychotics (haloperidol, pimozide), opioid analgesics (methadone, fentanyl, alfentanil), anticonvulsants (phenytoin, carbamazepine, phenobarbital), blood thinner (warfarin), anti-HIV drug (rifampicin), antifungals (itraconazole, ketoconazole, voriconazole) and immunosuppressants (cyclosporine, tacrolimus, sirolimus). Inform your doctor if you are using any medicines before taking Tasigna 150Mg Capsule.
Drug-Food Interaction: Avoid grapefruit juice, grapefruit and any supplement containing grapefruit extract while taking Tasigna 150Mg Capsule as it may increase the amount of Nilotinib in the body and cause serious side effects. Also, Tasigna 150Mg Capsule may interact with St. John’s wort (a herbal product used to treat depression).
Drug-Disease Interaction: Avoid taking Tasigna 150Mg Capsule if you have low levels of magnesium or potassium in the blood or long QTc syndrome. If you have had pancreatitis, stroke or other problems due to decreased blood flow to the brain, have QTc prolongation or a family history of it, bleeding problems, irregular heartbeat, have low problems with decreased blood flow to your legs, have low levels of magnesium or potassium in blood, heart or liver problems, inform your doctor before taking Tasigna 150Mg Capsule.
The interaction of Tasigna 150Mg Capsule with alcohol is unknown. Please discuss with your doctor if you have any concerns regarding this.
Tasigna 150Mg Capsule is not recommended for use during pregnancy as it may harm the unborn baby. Therefore, inform your doctor if you are pregnant or planning for pregnancy before taking Tasigna 150Mg Capsule. Also, you are advised to use effective birth control measures during treatment with Tasigna 150Mg Capsule and for up to 2 weeks after the last dose of Tasigna 150Mg Capsule.
You are recommended to avoid breastfeeding during treatment with Tasigna 150Mg Capsule and for two weeks after the final dose. Inform your doctor if you are breastfeeding.
If you experience side effects such as dizziness or visual disorders, avoid driving or operating machinery until you are alert.
Inform your doctor if you have liver problems before taking Tasigna 150Mg Capsule. Your doctor may adjust the dose if necessary based on your condition.
Limited information is available on the use of Tasigna 150Mg Capsule in patients with impaired kidney function. Therefore, if you have kidney problems, inform your doctor before taking Tasigna 150Mg Capsule.
Tasigna 150Mg Capsule is not recommended for children below 1 year of age as the safety and effectiveness were not established.
Regular tests are recommended during treatment with Tasigna 150Mg Capsule:
This item is Not Returnable.
Expires on or after - Sep-23
Philadelphia chromosome-positive chronic myeloid leukemia (Ph+ CML): It is a common form of chronic myeloid leukemia (CML) that occurs when specific chromosomes swap positions, causing an abnormality in the chromosomes, creating the Philadelphia chromosome. The abnormal chromosomes produce an abnormal protein called Bcr-Abl tyrosine kinase, which then triggers a signal to produce abnormal white blood cells in the bone marrow. CML is a type of blood cancer which makes the body produce too many abnormal white blood cells. Many people with Ph+ CML will not experience symptoms before their diagnosis. However, if symptoms do occur, they include weight loss, weakness, night sweats, extreme tiredness, feeling full after only small meals, bone pain, and easy bleeding.
United States
Sandoz House, Shiv Sagar Estate, Worli Mumbai -400 018, India
While we strive to provide complete, accurate, and expert-reviewed content on our 'Platform', we make no warranties or representations and disclaim all responsibility and liability for the completeness, accuracy, or reliability of the aforementioned content. The content on our platform is for informative purposes only, and may not cover all clinical/non-clinical aspects. Reliance on any information and subsequent action or inaction is solely at the user's risk, and we do not assume any responsibility for the same. The content on the Platform should not be considered or used as a substitute for professional and qualified medical advice. Please consult your doctor for any query pertaining to medicines, tests and/or diseases, as we support, and do not replace the doctor-patient relationship.
(Inclusive of all taxes)
Provide Delivery Location
Strip
1 Capsule in 1 Strip